Marex Group PLC Io Biotech, Inc. Call Options Transaction History

Marex Group PLC

  • $11.1 Billion
  • Q2 2025

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About IO Biotech, Inc.

IOBT Quotes by TradingView
  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $50.7M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Marex Group PLC Portfolio

Follow Marex Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marex Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Marex Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email